Here’s Mark’s key message: The time of the $1000 genome meme is over. It served us well for years – driving advances in instrumentation, chemistry and biology. But now it is reducing clinical credibility. It’s time for it to leave the lexicon of healthcare; it has to go.
View the original article here: Cancer, Data and the Fallacy of the $1000 Genome – Forbes
 |
Infographics | More... |
Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar? 
30 years later in Romania: What happened to the babies deprived of human contact? 
Evolution’s ‘great leap forward’: When did humans cross the intelligence rubicon? 
Viewpoint: Agribashing and the French media — Paper withdraws ‘fake news’ viral article claiming drinking water contains 200 ‘dangerous’ chemicals 
Why is it so difficult to find a treatment for Huntington’s Disease? 
How common is incest? Rise of genetic testing reveals disturbing evidence 
Embryos aren’t female by ‘default’ after all, study shows 
Viewpoint: Iowa farmer explains support for state bill to restrict suits against manufacturers of glyphosate and other pesticides that follow federal guidelines 
‘Golden blood’ is incredibly important to medicine — but for the 43 people worldwide known to have it, it poses a unique danger 
Gene-edited chickens could reduce the threat of bird flu spread and promote sustainability 
